Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer

Cancer Letters

Volumn 246, Issue 1-2, 2007, Pages 109-114

  Wen, Xia ^a   Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Benzo a pyrene; CYP1B1; Esophageal carcinogenesis; Methoxylated flavones

Indexed keywords

3',4' DIMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; BENZO[A]PYRENE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; FLAVONE DERIVATIVE; FLAVONOID; MESSENGER RNA; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; RESVERATROL;

ARTICLE; CANCER RISK; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG TARGETING; ENZYME REGULATION; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UPREGULATION;

ARYL HYDROCARBON HYDROXYLASES; BENZO(A)PYRENE; BLOTTING, WESTERN; CELL LINE; CYTOCHROME P-450 CYP1A1; DNA; DNA ADDUCTS; ESOPHAGEAL NEOPLASMS; FLAVONES; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; RNA, MESSENGER; TIME FACTORS;

EID: 33845645957     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.02.003     Document Type: Article

References (37)

1. Pfeifer G.P., Denissenko M.F., Olivier M., Tretyakova N., Hecht S.S., and Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 multations in smoking-associated cancers. Oncogene 21 (2002) 7435
2. Stoner G.D., and Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22 (2001) 1737
3. Brennan J.A., Boyle J.O., Koch W.M., Goodman S.N., Hruban R.H., Eby Y.J., et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 332 (1995) 712-717
4. Snyder L.A., Bertone E.R., Jakowski R.M., Dooner M.S., Jennings-Ritchie J., and Moore A.S. p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Vet. Pathol. 41 (2004) 209-214
5. Wen X., and Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26 (2005) 1774-1781
6. Stoner G., Kaighn M., Reddel R., Resau J., Bowman D., Naito Z., et al. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res. 51 (1991) 365-371
7. De Stefani E., Ronco A., Mendilaharsu M., and Deneo-Pellegrini H. Diet and risk of cancer of the upper aerodigestive tract-II. Nutrients Oral. Oncol. 35 (1999) 22-26
8. Schrump D.S., and Nguyen D.M. Strategies for molecular intervention in esophageal cancers and their precursor lesions. Dis. Esophagus 12 (1999) 181-185
9. Wen X., Walle U.K., and Walle T. 5,7-Dimethoxyflavone down-regulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26 (2005) 803-809
10. P.A. Tsuji and T. Walle, Inhibition of benzo[a]pyrene-activating enzymes and DNA-binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis, in press.
11. Orlando G., Tobey N., Wang P., Abdulnour-Nakhoul S., and Orlando R. Regulatory volume decrease in human esophageal epithelial cells. Am. J. Physiol. 283 (2002) G932-G937
12. Walgren R.A., Walle U.K., and Walle T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55 (1998) 1721-1727
13. Walle T., Vincent T.S., and Walle U.K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol. 65 (2003) 1603-1610
14. Slomiany B.A., Kelly M.M., and Kurtz D.T. Extraction of nuclear proteins with increased DNA binding activity. BioTechniques 28 (2000) 938-942
15. Hartley D.P., and Klaassen C.D. Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology. Drug Metab. Dispos. 28 (2000) 608-616
16. Shou M., Korzekwa K.R., Crespi C.L., Gonzalez F.J., and Gelboin H.V. The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol. Carcinog. 10 (1994) 159-168
17. Xue W., and Warshawsky D. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol. Appl. Pharmacol. 206 (2005) 73-93
18. Murray G.I., Shaw D., Weaver R.J., McKay J.A., Ewen S.W., Melvin W.T., et al. Cytochrome P450 expression in oesophageal cancer. Gut 35 (1994) 599-603
19. Nakajima T., Wang R.S., Nimura Y., Pin Y.M., He M., Vainio H., et al. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis 17 (1996) 1477-1481
20. Lechevrel M., Casson A.G., Wolf C.R., Hardie L.J., and Flinterman M.B. Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis 20 (1999) 243-248
21. Hughes S.J., Morse M.A., Weghorst C.M., Kim H., Watkins P.B., Guengerich F.P., et al. Cytochromes P450 are expressed in proliferating cells in Barrett's metaplasia. Neoplasia 1 (1999) 145-153
22. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicology and cancer. J. Biol. Chem. 279 (2004) 23847-23850
23. Zhang S., Qin C., and Safe S. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ. Health Perspect 111 (2003) 1877-1882
24. Mollerup S., Øvrebø S., and Haugen A. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells. Int. J. Cancer 92 (2001) 18-25
25. Murray G.I., Melvin W.T., Greenlee W.F., and Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 297-316
26. Lee J.-E., and Safe S. 3′,4′-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol. Sci. 58 (2000) 235-242
27. Palermo C.M., Westlake C.A., and Gasiewicz T.A. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 44 (2005) 5041-5052
28. Tsuchiya Y., Nakajima M., and Yokoi T. Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene. J. Biochem. (Tokyo) 133 (2003) 583-592
29. Tokizane T., Shiina H., Igawa M., Enokida H., Urakami S., Kawakami T., et al. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin. Cancer Res. 11 (2005) 5793-5801
30. Hollman P.C., vd Gaag M., Mengelers M.J., van Trijp J.M., de Vries J.H., and Katan M.B. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radical Biol. Med. 21 (1996) 703-707
31. Manach C., Morand C., Crespy V., Demigne C., Texier O., Regerat F., et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. Fed. Eur. Biochem. Soc. Lett. 426 (1998) 331-336
32. Walle T. Absorption and metabolism of flavonoids. Free Radical Biol. Med. 36 (2004) 829-837
33. Walle T., Otake Y., Brubaker J.A., Walle U.K., and Halushka P.V. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br. J. Clin. Pharmacol. 51 (2001) 143-146
34. Walle T., Hsieh F., DeLegge M.H., Oatis J.E.J., and Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32 (2004) 1377-1382
35. X. Wen, T. Walle, Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica, in press.
36. Ahmad F., Bakar S.A., Ibrahim A.Z., and Read R.W. Constituents of the leaves of Piper caninum. Planta Med. 63 (1997) 193-194
37. Budzianowski J., Morozowska M., and Wesolowska M. Lipophilic flavones of Primula veris L. from field cultivation and in vitro cultures. Phytochem 66 (2005) 1033-1039